David Guzo

Array ( [id] => 6735135 [patent_doc_number] => 20030012770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Recombinant p53 adenovirus methods and compositions' [patent_app_type] => new [patent_app_number] => 10/170240 [patent_app_country] => US [patent_app_date] => 2002-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14259 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20030012770.pdf [firstpage_image] =>[orig_patent_app_number] => 10170240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6258626 [patent_doc_number] => 20020187129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Adeno-associated virus materials and methods' [patent_app_type] => new [patent_app_number] => 10/163886 [patent_app_country] => US [patent_app_date] => 2002-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7089 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187129.pdf [firstpage_image] =>[orig_patent_app_number] => 10163886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847064 [patent_doc_number] => 20030166231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Novel human RNA-binding protein' [patent_app_type] => new [patent_app_number] => 10/159188 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18074 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166231.pdf [firstpage_image] =>[orig_patent_app_number] => 10159188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1094923 [patent_doc_number] => 06821512 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-23 [patent_title] => 'Compositions and methods for increasing packaging and yield of recombinant adenoviruses using multiple packaging signals' [patent_app_type] => B1 [patent_app_number] => 10/169544 [patent_app_country] => US [patent_app_date] => 2002-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8739 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/821/06821512.pdf [firstpage_image] =>[orig_patent_app_number] => 10169544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697278 [patent_doc_number] => 20030109472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Replicating adenovirus vectors' [patent_app_type] => new [patent_app_number] => 10/159946 [patent_app_country] => US [patent_app_date] => 2002-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17696 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109472.pdf [firstpage_image] =>[orig_patent_app_number] => 10159946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6635231 [patent_doc_number] => 20030211599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Minicell-based delivery agents' [patent_app_type] => new [patent_app_number] => 10/157106 [patent_app_country] => US [patent_app_date] => 2002-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 143595 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211599.pdf [firstpage_image] =>[orig_patent_app_number] => 10157106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865223 [patent_doc_number] => 20030190749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Minicell-producing parent cells' [patent_app_type] => new [patent_app_number] => 10/157215 [patent_app_country] => US [patent_app_date] => 2002-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 143348 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20030190749.pdf [firstpage_image] =>[orig_patent_app_number] => 10157215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6821727 [patent_doc_number] => 20030219888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Minicell-based bioremediation' [patent_app_type] => new [patent_app_number] => 10/157418 [patent_app_country] => US [patent_app_date] => 2002-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 143213 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219888.pdf [firstpage_image] =>[orig_patent_app_number] => 10157418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6476174 [patent_doc_number] => 20020151686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Recombinant soluble adenovirus receptor' [patent_app_type] => new [patent_app_number] => 10/155282 [patent_app_country] => US [patent_app_date] => 2002-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6925 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151686.pdf [firstpage_image] =>[orig_patent_app_number] => 10155282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660015 [patent_doc_number] => 20030079248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Gemini virus vectors for gene expression in plants' [patent_app_type] => new [patent_app_number] => 10/151336 [patent_app_country] => US [patent_app_date] => 2002-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 26341 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20030079248.pdf [firstpage_image] =>[orig_patent_app_number] => 10151336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6855668 [patent_doc_number] => 20030129169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Novel expression vectors and uses thereof' [patent_app_type] => new [patent_app_number] => 10/138098 [patent_app_country] => US [patent_app_date] => 2002-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 100 [patent_figures_cnt] => 100 [patent_no_of_words] => 32854 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129169.pdf [firstpage_image] =>[orig_patent_app_number] => 10138098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6562426 [patent_doc_number] => 20020164802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer' [patent_app_type] => new [patent_app_number] => 10/136139 [patent_app_country] => US [patent_app_date] => 2002-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13144 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164802.pdf [firstpage_image] =>[orig_patent_app_number] => 10136139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7406125 [patent_doc_number] => 20040175830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'PHAGEMID VECTORS' [patent_app_type] => new [patent_app_number] => 10/134188 [patent_app_country] => US [patent_app_date] => 2002-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 5158 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20040175830.pdf [firstpage_image] =>[orig_patent_app_number] => 10134188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774846 [patent_doc_number] => 20030018184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor' [patent_app_type] => new [patent_app_number] => 10/127691 [patent_app_country] => US [patent_app_date] => 2002-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11798 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20030018184.pdf [firstpage_image] =>[orig_patent_app_number] => 10127691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6787166 [patent_doc_number] => 20030138405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Conditionally replicative adenovirus to target the Rb and Rb-related pathways' [patent_app_type] => new [patent_app_number] => 10/124608 [patent_app_country] => US [patent_app_date] => 2002-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 33865 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138405.pdf [firstpage_image] =>[orig_patent_app_number] => 10124608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 736975 [patent_doc_number] => 07033826 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-25 [patent_title] => 'Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses' [patent_app_type] => utility [patent_app_number] => 10/121616 [patent_app_country] => US [patent_app_date] => 2002-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11784 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/033/07033826.pdf [firstpage_image] =>[orig_patent_app_number] => 10121616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5788484 [patent_doc_number] => 20020160977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Method for selective inactivation of viral replication' [patent_app_type] => new [patent_app_number] => 10/112547 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 51042 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160977.pdf [firstpage_image] =>[orig_patent_app_number] => 10112547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6568126 [patent_doc_number] => 20020165194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Method for selective inactivation of viral replication' [patent_app_type] => new [patent_app_number] => 10/112241 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 51044 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165194.pdf [firstpage_image] =>[orig_patent_app_number] => 10112241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852023 [patent_doc_number] => 20030144226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Method for selective inactivation of viral replication' [patent_app_type] => new [patent_app_number] => 10/109368 [patent_app_country] => US [patent_app_date] => 2002-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 50991 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144226.pdf [firstpage_image] =>[orig_patent_app_number] => 10109368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5788481 [patent_doc_number] => 20020160976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Method for selective inactivation of viral replication' [patent_app_type] => new [patent_app_number] => 10/104611 [patent_app_country] => US [patent_app_date] => 2002-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 51003 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160976.pdf [firstpage_image] =>[orig_patent_app_number] => 10104611 [rel_patent_id] =>[rel_patent_doc_number] =>)